background impact polymorphic amino acids NUMBER NUMBER beta beta susceptibility bronchodilator tolerance remains unclear clinical studies far shown discordant results tolerance effects inhaled beta agonists generally easily shown systemic parameters airway effects substantial study evaluates differences exist position NUMBER homozygous genotyped asthmatics tolerance development airway responses systemic effect hypokalemia methods patients genotyped amino acids NUMBER NUMBER beta gene curves fev1 serum potassium concentration constructed sc administration terbutaline treatment periods terbutaline inhalation matching placebo randomised design statistical analysis repeated measures multivariate analysis area curve auc main results inhaled terbutaline did influence improvement fev1 response sc terbutaline significant differences individuals respect inhaled terbutaline resulted overall increase baseline plasma potassium administration sc terbutaline p0034 effect appeared solely confined homozygous individuals leading statistically highly significant difference subjects p0005 genotype related difference decrease plasma potassium response sc terbutaline relative baseline conclusion patients carrying genotype development hypokalemia sc terbutaline attenuated inhaled terbutaline basis higher baseline values NUMBER adrenoceptor NUMBER ar NUMBER ar NUMBER ar time effect week double blind cross time effect pre treatment arg NUMBER gly NUMBER pre treatment NUMBER NUMBER arg NUMBER arg NUMBER gly NUMBER arg NUMBER pre treatment mmol l